Osmotic nephrosis in a renal transplant recipient

Kidney International

Volumn 70, Issue 10, 2006, Pages 1873-1876

  Ebcioglu, Z ^a   Cohen, D J ^a   Crew, R J ^a   Hardy, M A ^a   Ratner, L E ^a   D'Agati, V D ^a   Markowitz, G S ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; HETASTARCH; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TACROLIMUS; VASOPRESSIN;

ADULT; ANAMNESIS; ANURIA; ARTICLE; CASE REPORT; FLOW CYTOMETRY; GRAFT DYSFUNCTION; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY GRAFT; LABORATORY TEST; MALE; NEPHROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY;

HETASTARCH; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; KIDNEY TUBULES, PROXIMAL; MALE; MIDDLE AGED; NEPHROSIS; OSMOSIS; PLASMA SUBSTITUTES; TRANSPLANTATION;

EID: 33750592384     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001737     Document Type: Article

References (17)

1. Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta 2005; 351: 31-47.
2. Anderson WAD, Bethea WR. Renal lesions following administration of hypertonic solutions of sucrose. JAMA 1940; 114: 1983-1987.
3. Lindberg HA, Wald MH, Barker MH. Renal changes following administration of hypertonic solutions. Arch Int Med 1939; 63: 907-918.
4. Rigdon RH, Cardwell ES. Renal lesions following the intravenous injection of a hypertonic sucrose solution. Arch Int Med 1942; 69: 670-690.
5. Maunsbach AB, Madden SC, Latta H. Light and electronic microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose or dextran. Lab Invest 1962; 11: 421-426.
6. Chacko B, John GT, Balakrishnan N et al. Osmotic nephrosis resulting form maltose-based intravenous immunoglobulin therapy. Ren Fail 2006; 28: 193-195.
7. Jungheinrich C, Neff T. Pharmacokinetics of hydroxyethylstarch. Clin Pharmacokinet 2005; 44: 681-699.
8. Wiedermann CJ. Hydroxyethyl starch - can the safety problems be ignored? Wien Klin Wochenschr 2004; 116: 583-594.
9. Kozek-Langenecker S. Effects of hydroxyethylstarch solutions on hemostasis. Anesthesiology 2005; 103: 654-660.
10. Legendre C, Thervet E, Page B. Hydroxyethylstarch and osmotic nephrosis like lesions in kidney transplantation. Lancet 1993; 342: 248-249.
11. Cittanova ML, Leblanc I, Legendre C et al. Effect of hydroxyethylstarch in brain dead kidney donors on renal function in kidney transplant recipients. Lancet 1996; 348: 1620-1622.
12. Schortgen F, Lacherade JC, Bruneel F et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001; 357: 911-916.
13. De Labarthe A, Jacobs F, Blot F. Acute renal failure secondary to hydroethyl starch administration in a surgical patient. Am J Med 2001; 111: 417-418.
14. Peron S, Mouthon L, Guettier C et al. Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 2001; 55: 408-411.
15. Boldt J, Brenner T, Lehmann A et al. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intens Care Med 2003; 29: 763-769.
16. Wiesen P, Canivet JL, Ledoux D et al. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg 2005; 56: 257-263.
17. Pillebout E, Nochy D, Hill G et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005; 5: 1120-1129.